← back to search

Duncan B. McLaren

NHS Lothian · GB
Area of research
Pulmonary and Respiratory Medicine · Radiation
Research interest
Research interests include Prostate Cancer Diagnosis and Treatment, Prostate Cancer Treatment and Research, Advanced Radiotherapy Techniques, and Radiomics and Machine Learning in Medical Imaging.
h-index
27
citations
5,412
works
145
NIH funding
primary concept
Medicine
email

Recent publications

Docetaxel for Nonmetastatic Prostate Cancer: Long-Term Survival Outcomes in the STAMPEDE Randomized Controlled Trial
JNCI Cancer Spectrum 2022cited by 25position: middledoi
Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial
The Lancet Oncology 2019cited by 640position: middledoi
Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol
Annals of Oncology 2018cited by 250position: middledoi
Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness
European Urology Oncology 2018cited by 27position: middledoi
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
The Lancet 2015cited by 1,957position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

No co-authors indexed yet.